View Document Preview and Link Document Date: 2009-04-30 23:31:43 Open Document File Size: 85,30 KB Share Result on Facebook
Company the New York Times / Fellowship / BBC news / LIFE / Google / Pharmalink / Al Ahram Weekly / / Country Saudi Arabia / Egypt / Pakistan / United States / Australia / Nigeria / China / / Event FDA Phase / / Facility Jedda airport / / IndustryTerm search option / pharmaceutical / defunct magazine / injectable biologic product / chemical substances / Treatment of a group of different rare diseases / / MedicalCondition rare diseases / inflammatory process / polio vaccination certificate / muscle weakness / Polio mother / polio vaccine makes children / inflammatory cytokines / polio vaccination Alhajl Bulama Ali / polio vaccine / disorder / polios / epidemics / orphan treatments Orphan diseases / back pain / different rare diseases / Orphan diseases / orphan disease / US polio survivors / polio survivors Dr Richard Bruno / hypertension / bulbar polio / oral polio vaccine / rare neuromuscular diseases / muscles spasm / rare disease / polio / same disease / pain / chest wall paralysis / diseases / respiratory insufficiency / Post-Polio Syndrome / polio vaccination / inflammation / Polio Paralympians Polio / polio survivors / / MedicalTreatment vaccination / surgery / dental surgery / / Organization Food and Drug Administration / Pakistani Ministry of Religious Affairs / European Neuromuscular Center / FDA / Saudi Arabian government / / Person Richard Bruno / Ask / Alhajl Bulama Ali / Marjorie Lawrence / Graham Ball / Xiao Cuijuan / / Position researcher / dental chair / head / chief / CEO / dentist / chair / / Product Xepol / / ProvinceOrState Maisandari / / PublishedMedium The International News / Al Ahram Weekly / the BBC news / the New York Times / / SportsEvent the 2008 Paralympic Games / the Olympic Games / / Technology GPS / / URL http / SocialTag 
Polio Particles 29 Mary Westbrook Positive results in trial of Xepol for PPS In February 2007 Polio Particles reported the results on a randomised, placebo controlled, double blind trial of intravenous immunoglobulin for